Status:
COMPLETED
Ultrasound Guided Transversus Abdominis Plane (TAP) vs. Trigger Point Injection (TPI) for Abdominal Wall Pain
Lead Sponsor:
Mayo Clinic
Conditions:
Abdominal Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Patients with chronic abdominal pain- with a component of abdominal wall pain- are often treated with trigger point injections. This study will help to determine if a block within the transversus abdo...
Detailed Description
Only patients referred to the Pain Clinic for abdominal trigger point injections for abdominal wall pain will be considered for study recruitment. Following informed consent, patients will complete a...
Eligibility Criteria
Inclusion
- Only patients referred to Pain Clinic for a trigger point injection.
- Non-cancer pain greater than 3 months duration.
- Unilateral abdominal pain.
- Positive Carnett's sign (A test in which acute abdominal pain remains unchanged or increases when the muscles of the abdominal wall are tensed.)
- An identifiable abdominal trigger point.
Exclusion
- History of chronic psychotic disorder.
- History of dementing illness.
- Active abdominal visceral disease as a known contributor of the pain.
- Abdominal surgery in the past 6 months.
- More than one trigger point.
- Abdominal wall hernias.
- BMI\>40.
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 18 2019
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT01906944
Start Date
January 1 2012
End Date
August 18 2019
Last Update
May 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905